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ABSTRACT
DNA POLYMERASE IOTA PROMOTES G2/M CHECKPOINT ACTIVATION AND
GENETIC STABILITY AFTER UV-INDUCED DNA DAMAGE
By: Lindsey Jay Stallons
June 3, 2011
Unrepaired DNA damage poses a serious threat to the genetic stability of a
replicating cell. One mechanism of tolerating this damage is translesion DNA synthesis
(TLS), in which an accessory polymerase synthesizes DNA directly across from a
damaged template. TLS is carried out by polymerase 11 (Pol 11), 1,

K,

and REV 1 in the Y-

family and Pol i; in the B-family. Pol 11 has the well-characterized ability to perform
accurate bypass of the most common UV-induced DNA lesion; loss of Pol 11 results in
hypermutability and severely increased risk of skin cancer. The high mutation frequency
in Poll1-deficient cells has been attributed to the mutagenic TLS activity of Poll.
Deletion of Pol 1 in the Poll1-deficient background results in greatly reduced UV-induced
mutation frequencies, but unexpectedly the double knockout mice develop cancer Jaster
than mice deficient in Pol 11 alone. This unexpected finding suggests that POll may have
a cellular role outside of TLS, which we investigated using a gene expression approach.
Poll-proficient and -deficient cells showed markedly different mRNA and microRNA
expression changes after UV treatment. Bioinformatics analysis revealed that the G2/M
checkpoint was the main point of divergence in the transcriptional response. Western

v

blotting showed that G2/M markers were increased and G liS markers were decreased 24
hours after UV treatment in Pol t-proficient cells, indicating an active checkpoint. Loss
of Pol t reversed these trends. FACS analysis of cell cycle kinetics showed a timedependent increase in the number of aneuploid Pol t-deficient cells after UV treatment;
this degree of genetic instability was not seen in Pol t-proficient cells. We also examined
the effects of Pol t on UV carcinogenesis in isogenic mice lacking Xpa, a gene central to
the repair ofUV-induced DNA damage. Loss of Pol t caused a trend towards reduced
tumor latency (p=O.057), while Poll1-deficiency caused a highly significant reduction in
tumor latency (p<O.Ol). These results indicate that Pol t plays a role in G2/M checkpoint
regulation and suppressing UV carcinogenesis. At the cost of frequent point mutations,
Pol t could help cells avoid death by resolving stalled replication forks and preventing
double strand breaks.
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CHAPTER I
INTRODUCTION
Segments of this chapter were published in the Journal of Nucleic Acids (2010).
General Introduction
Tumorigenesis is a multi-step process beginning with the transformation of a
single cell by the accumulation of at least six distinct characteristics. These include
infinite lifespan, resistance to anti-growth signals, resistance to apoptosis, autocrine
production of growth signals, sustained angiogenesis, and tissue invasion [1]. These
properties are regulated by genes in two categories: protooncogenes and tumor
suppressors. Protooncogenes are normal cellular genes that can be overexpressed due to
genetic changes, causing cellular transformation. A tumor suppressor is a gene that
protects a cell from transformation, and loss of expression of these genes can, in concert
with other genetic changes, lead to carcinogenesis.
Most environmental carcinogens induce transformation by causing mutations in
the DNA that alter the activity of protooncogenes or tumor suppressors. These mutations
are formed when residual, unrepaired DNA damage stalls progression of the replication
fork during S phase. Stalled replication forks are most frequently resolved using errorfree mechanisms that include homologous recombination or use of the homologous
nascent strand as a template. Nevertheless, replication may proceed using the damaged
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strand as a template in an error-prone process known as translesion DNA synthesis
(TLS). TLS is defined as the incorporation of a nucleotide across from DNA damage
followed by extension of the potentially mispaired primer-template, and can be error-free
or error-prone.
Cellular commitment to error-free, recombinatorial damage avoidance or errorprone TLS is modulated by the molecular switch proliferating cell nuclear antigen
(PCNA) (Fig. 1-1). Bulky DNA lesions can cause blockage of replicative polymerases
and replication fork stalling. The ubiquitin conjugase/ubiquitin ligase pair Rad6/Rad 18 is
recruited to stalled replication forks where the proteins catalyze monoubiquitylation of
PCNA at lysine 164. TLS proteins such as REVI and Pol 11 have increased affinity for
monoubiquitylated PCNA, which facilitates their recruitment and the completion of TLS
[2]. In yeast, Rad5 and the MMS2-Ubc13 complex (UBE2V2-UBE2N in humans) can
catalyze polyubiquitylation of PCNA via lysine 63 of ubiquitin, which blocks TLS and
activates error-free damage avoidance [3]. Damage avoidance includes template
switching, during which the nascent DNA strand from the sister duplex is used as an
undamaged homologous template to replicate past the lesion. Humans express two Rad5
homologs, SHPRH and HLTF, and both catalyze K-63-linked polyubiquitylation of
PCNA in human cells [4,5,6,7]. In yeast, Ubc9-Sizl can attach the small ubiquitin-like
modifier (SUMO) to lysine 164 ofPCNA in a reaction that competes with Rad6/Radl8mediated monoubiquitylation. PCNA SUMOylation at K-I64 attracts the helicase Srs2
and prevents error-prone RAD52-dependent recombination [8].
Cells presumably risk mutations caused by TLS to relieve replication fork
blockage at DNA adducts and to avoid the potential formation of extremely cytotoxic
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double strand breaks (DSB). Although it accounts for less than 10% of all bypass
synthesis events in yeast [9], the frequency of potentially mutagenic TLS may be as high
as 50% in higher eukaryotes [10,11,12]. The propensity and mutagenic potential ofTLS
explain why it is etiologic in most environmentally-induced cancers and has been the
focus of numerous investigations over the past decade.
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Fig. 1-1. Regulation of DNA lesion bypass in Saccharomyces cerevisiae. Replication
fork stalling causes Rad6-Rad18 recruitment and monoubiquitylation of PCNA, causing
subsequent recruitment of TLS proteins which preferentially bind monoubiquitylated
PCNA. Rad5 and the MMS2-Ubc 13 complex can catalyze polyubiquitylation of
monoubiquitylated PCNA, blocking TLS and activating the error-free damage avoidance
pathway. In addition, Ubc9-Siz1 can add SUMOylate PCNA in the same position that
Rad6-Rad18 monoubiquitylate it, blocking TLS and damage avoidance and promoting
error-prone RAD52-dependent recombination. Reproduced with permission from
Watson N B et ai, Cancer Lett. 2006 Sep 8;241(1):13-22. Copyright 2006 Elsevier
Ireland Ltd.
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TLS is perfonned by a relatively new category of accessory DNA polymerases.
Polymerase 11 (Pol 11), POll, Pol K, and REVI in the Y-family [13] and Pol 1:; in the Bfamily.[ 14, 15] are responsible for most TLS in mammalian cells. These proteins have
active sites that are larger and more open than those of the high-fidelity replicative DNA
polymerases (Pol a, 8, and E), allowing accommodation of and synthesis past DNA
templates with large, helix-distorting lesions [16]. This unique ability to synthesize DNA
opposite bulky adducts helps cells avoid double strand breaks associated with replication
fork stalling, but can also lead to mutagenesis by incorrect base addition. It is important
to note that polymerases in the Y -family are expressed in all three kingdoms of life,
indicating a critical and evolutionarily conserved role for these proteins [13]. The
obviously conflicting roles of these enzymes in both preventing and promoting genetic
instability are reflected in the tight cellular control of the TLS pathway (Fig. 1-1).
Although extensive in vitro studies have given us a better understanding of their role in
the cell, much less is known about the function of TLS polymerases in living animals.
Limited epidemiological studies have been conducted to associate single nucleotide
polymorphisms (SNPs) in TLS genes with cancer risk in humans [17,18]. Knockout
mice have been generated for each gene, and carcinogenesis studies are published [19,20]
or underway. Importantly, studies in mice and humans have shown that TLS
polymerases, particularly Pol 11, are involved in immunoglobulin gene hypennutation
[21], which is beyond the scope of this dissertation
REV1

REVI was discovered in budding yeast by the Lawrence group in 1989 as a
component of the Pol 1:; complex [22]. The catalytic activity of REV 1 is limited to
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insertion of dCMP across from a template dG [23]. The human homolog was cloned in
1999 and has the same template-dependent dCMP transferase catalytic activity on an
undamaged template or an abasic site [24]. One locus used in eukaryotic cells to measure
mutation frequency is HPRT, a gene involved in the purine salvage pathway. In this
forward mutation assay, cells with loss-of-function mutations in HPRT are resistant to the
drug 6-thioguanine (TG). REVI is required for carcinogen-induced HPRT mutagenesis
in human cells [25,26,27], but the catalytic activity appears to be dispensable for the
induction ofUV -induced mutations [28,29], indicating that this protein probably plays a
structural rather than catalytic role in UV mutagenesis.
Cells from mice with a targeted deletion of the BRCAI C-terminal (BRCT)
homology domain of Rev 1 (Rev1BIB) have a reduced UV-induced mutation frequency at
the Hprt locus [30]. However, the animals have a paradoxically decreased latency of
squamous cell carcinoma (SCC) formation and only marginally reduced p53 mutagenesis
in the skin after UV exposure [20]. Despite Rev 1BIB cells showing a moderate increase in
chromatid breaks and exchanges after UV in vitro [30], comparative genomic
hybriziation ofUV-induced SCC and normal skin DNA reveals no increase in the
frequency of gross genomic alterations in Rev 1BIB SCC [20]. If point mutations and
chromosomal rearrangements are near normal levels in BRCT -deleted Rev 1BIB mice, what
is the reason for accelerated SCC development? Acute UV exposure of these Rev1mutant mice induces enhanced Atr signaling, senescence, and apoptosis in the skin.
However, long-term low-dose UV exposure causes a mitogenic response, as evidenced
by epidermal hyperplasia, decreased apoptosis, and increased proliferation of CPDcontaining keratinocytes [20]. Based on literature reports of the etiological role oflL-6

6

in carcinogenesis and elevated IL-6 levels in the skin after a single subtoxic UV dose, the
authors conclude that error-prone TLS ofUV-induced DNA damage is responsible for
suppressing the proinflammatory, tumor-promoting effects ofUV in the skin. However,
more direct immunological studies are needed to confirm that Revl suppresses UVinduced inflammation and tumor suppression.
REVI has also been implicated in TLS across other types of DNA lesions.
Benzo[a]pyrene dihydrodiolepoxide (BPDE) is the primary carcinogenic metabolite of
B[a]P and causes point mutations in a REVI-dependent manner [27,31]. BPDE-induced
Hprt mutations are dramatically decreased in primary mouse fibroblasts after ribozyme-

mediated Rev i-knockdown. When a plasmid expressing this ribozyme is delivered to the
lungs of All mice by aerosol nebulization, Revi mRNA is reduced by -5%0 in the
bronchial epithelium. This targeted gene therapy causes a -40% reduction in the lung
tumor multiplicity after B[a]P treatment. In addition, only 73% ofribozyme-treated mice
develop lung adenomas after B[a]P, compared with 100% penetrance in control animals
[32]. This report highlights the potential for interrupting translesion synthesis as a
chemoprevention strategy.
Although no human disorder involving REVi deficiency is known, there are 16
SNPs in humans that result in nonsynonymous amino acid changes. The F257S SNP,
which lies outside of all known functional domains of the protein, has been associated
with an increased risk of squamous cell carcinoma of the lung in patients who have ever
smoked cigarettes [33]. However, this association remains controversial [34]. The same
F257S SNP was associated with decreased risk of cervical cancer, and N373S within the
catalytic domain was associated with increased risk of cervical cancer. Both effects were
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specific for squamous cell carcinoma and not relevant for adenocarcinoma of the cervix
[17]. Although the functional consequences of these polymorphisms are unknown, these
studies support a role for REV 1 in the formation of multiple internal cancers.
POL Yf

The study of trans lesion synthesis in mammals began in 1999 with the discovery
of the molecular defect that results in Xeroderma Pigmentosum (XP) variant syndrome.
All XP patients have dramatically increased susceptibility to UV-induced skin cancer
[35]. Patients in complementation groups A through G are deficient in nucleotide
excision repair (NER), the major pathway for removal of helix-distorting lesions,
including those induced by UV. However, the XP variant subset of patients has normal
NER activity [36,37], yet displays the skin cancer-prone phenotype ofNER-deficient
patients. The XP variant mystery persisted for nearly three decades. Intensive
investigations indicate that after UV-irradiation cells from these patients have difficulty
exiting S-phase that is exacerbated by caffeine [38,39]. Further, these cells are extremely
hypermutable after UV [40]. In 1999, two groups independently discovered that XP
variant patients carry autosomal recessive mutations in POLR, the human gene coding
for Pol 11, and that the enzyme can catalyze error-free DNA synthesis across from a
template TT cyclobutane pyrimidine dimer (CPD) [41,42,43]. The dramatic increase in
skin cancer risk of XP variant patients could now be explained by the absence of a critical
translesion DNA polymerase. UV principally induces photoaddition products between
intrastrand adjacent pyrimidines, the most frequent of which are TT CPD. These lesions
block progression of the replication fork. Data indicate that helicase activity may
continue in spite of the blocked replication complex, resulting in single-stranded DNA
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that is rapidly coated with replication protein A (RP A). This appears to attract the
ubiquitin ligase RADI8, which has binding sites for the ubiquitin conjugase RAD6, Pol
11, and RPA. One target of ubi quityl at ion is PCNA. Since Pol 11 has a ubiquitin binding
domain, Pol 11 is now thought to be preferentially attracted to the stalled fork because it is
chaperoned directly by RAD 18 and binds to the ubiquitylated PCNA (Fig. I ) [44]. Data
indicate that Pol 11 then incorporates AA across from TT CPO in the template. In the
absence of Pol 11, another translesion polymerase, which is potentially error-prone when
bypassing these common UV-induced lesions, accesses the damaged template(reviewed
in [2,45]). Generation of Pol 11-knockout mice shows that the highly homologous mouse
Pol 11 protein functions similarly in UV -induced mutagenesis and carcinogenesis. Pol 11deficient mice develop squamous cell carcinoma with 100% penetrance at a UV fluence
that does not cause any tumors in wild-type littermates. In addition, approximately onethird of heterozygous mice develop cancer after UV exposure [19]. This raises the
possibility that humans carrying heterozygous mutations in the POLH gene may have an
increased risk of developing skin cancer. However, this speculation has not been
clinically investigated.
There is evidence that XP variant patients develop internal cancers faster than Pol
11-proficient individuals [46,47], raising the possibility that Pol 11-deficiency is involved
in the formation of multiple human cancers caused by DNA damaging agents other than
UV. Six SNPs in POLHhave been found to date that result in non synonymous amino
acid substitutions, but their functional significance is unknown. There is a single study
evaluating the effects on cancer risk of POLH polymorphisms. Flanagan and colleagues
found no significant changes in coding-region SNPs of POLH among 40 basal cell
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carcinoma and squamous cell carcinoma patients in a fair-skinned Irish population [48].
It is clear that larger epidemiological studies of POLH status are needed to evaluate the

effects of POLH polymorphisms.
POLl

DNA polymerase 1 (Pol 1) was discovered in 1999 as a novel homolog of Pol 11 in
mammals and is encoded by the human POLl gene [49]. In vitro studies with purified
enzyme indicate error-prone TLS function on almost all substrates examined, perhaps due
to the still controversial ability of Pol 1 to incorporate incoming nucleotides using
Hoogsteen base pairing [50,51]. Exhaustive characterization of the error-prone
replication properties of Pol 1 has lent credibility to the hypothesis that Poll is a candidate
gene for the Pulmonary adenoma resistance 2 (Par2) locus in mice [52,53,54]. The Par2
locus was identified in 1996 by chromosomal linkage mapping between BALB/cJ and

All mouse strains and plays a major role in the relative resistance of BALB mice versus
the All strain to developing urethane-induced lung adenomas [55]. Wang et al identified
ten amino acid-substitution polymorphisms between All and BALB mice that produce
changes in substrate recognition of POll; while the enzyme from both strains is
functional, the isoform expressed in BALB mice may be more accurate on certain
undamaged templates [53]. These studies suggest that POll acts to suppress urethaneinduced lung adenomas. It has been hypothesized that this activity is due to the
augmentation of base excision repair (BER) by POll, because the enzyme has
5'deoxyribose phosphate (dRP) lyase activity and can partially reconstitute the BERdeficiency of Pol

~-null

cells in vitro [56]. It is possible that after urethane-induced DNA

damage, which produces 1,N'-ethenoadenine adducts [57] that are primarily repaired by
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BER [58], Pol t acts in the gap-filling step of lesion repair. If the isoform of Pol t
expressed in All mice is more likely to add the incorrect G opposite a template T in the
gap-filling step ofBER, as was found in vitro [53], this could explain the increased
incidence oflung adenomas in All mice. In support of this hypothesis, nearly all
urethane-induced adenomas in mice have a CAA 7CGA transition in codon 61 of Kras2
[52]. In addition, 129-derived mouse strains that carry a SNP in codon 27 of Pob
resulting in a severely truncated protein [59] display extreme sensitivity to urethaneinduced lung adenomas [54]. Despite reports that splice variants of Pob can exclude
ex on two [53], which contains the premature stop codon in 129 mice, and that brain
extracts from 129 mice show Pol t activity in a complex in vitro assay [60], a recent
report clearly showed that the isoform of Pol t missing exon two is catalytically inactive
[61]. Thus, 129 mice either express a severely truncated 26 amino acid Pol t protein, or
an isoform lacking exon two which contains two of the three residues that make up the
catalytic triad of the active site. In either case, the functional effect is Polz deficiency.
In the absence of Pol t, it has been hypothesized that another DNA polymerase,
such as Pol

~,

inserts the incorrect base during gap filling in the repair of urethane-

induced DNA damage. However, normal mouse Pol t displays extremely error-prone
properties during synthesis opposite all four undamaged template bases in vitro [59],
making it unlikely to prevent mutations during BER in mice that are Pol t-competent.
Further studies must be completed to determine the tumor suppression mechanism of Pol
t in mouse lung carcinogenesis.
A growing body of evidence suggests that Pol t is involved in error-prone TLS of
UV-induced DNA damage in vivo. The heightened UV mutagenesis ofPollj-null (XP
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variant) human cells has been attributed to TLS by Pol t [62]. Loss of the functional Polz
gene in dermal cells results in a dramatically reduced UV-induced mutation frequency at
the Hprt locus in both wild-type and Pol ll-deficient mice (Fig. 1-2). Remarkably,
however, the decreased UV-induced mutagenesis observed due to loss of the error-prone
Pol t from Pol ll-deficient mice is associated with increased cancer risk after UV
exposure(Fig. 1-3) [63]. This result was confirmed and extended by Ohkumo and
colleagues who showed that Po/(i- mice are more likely to develop aggressive
mesenchymal tumors after UV than Polz-proficient siblings [64]. These apparently
contradictory findings speak to the fact that cancer etiology is more complex than the
point mutations scored by the Hprt assay, and that one cannot use cell biology alone to
accurately predict cancer risk in a TLS model. Indeed, they suggest a tumor suppressor
role for Pol t that could be separate from its role as a TLS polymerase prone to induce
single base-substitution mutations. It is also possible that Pol t is error-free when
bypassing a minor UV adduct, or that it is involved in error-free BER of the minimal
oxidative damage induced by UVB used in these studies [65], but more detailed
experiments must be performed to evaluate these possibilities.
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Fig. 1-2. Frequency of 6-thioguanine-resistant (TG T) clones as a function of survival after
UV irradiation. Cells were plated on three ISO-mm-diameter dishes at a density of 104
cm-2 to determine mutant frequency or at cloning density to determine survival. After
attachment, plates were irradiated with UV fluences to yield 20-40% survival. The actual
survival in the mutagenesis experiments was determined by refeeding the survival plates
at one week and staining with crystal violet after two weeks. Percent survival for each
UV fluence was corrected for replating and plotted on the x-axis. The corresponding
mutant frequency at each survival is plotted on the y-axis. Each point represents the mean
of three independent dishes at the indicated survival, ±1 SD. Mutant frequency at the

Hprt locus is defined as the number of TGT clones per million clonable cells. Each data
point represents independent experiments in which 2-4

x

106 surviving cells were

selected after UV irradiation and an 8- to 9-day expression period. The data have been
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corrected for cloning efficiency on the day of selection, and the spontaneous background
mutant frequency (1

x

10-5 ) has been subtracted. The arrows indicate the reduction in

mutant frequency when Poll is disrupted in the Pol Tj-deficient background (larger arrow)
and in the Pol Tj-proficient background (smaller arrow). Reproduced with permission
from DumstorfC A et al. PNAS 2006;103:18083-18088, Copyright 2006 National
Academy of Sciences, USA.
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irradiated three times per week with 3.75 kJ/m2 for 20 weeks or until the first skin tumor
arose. Mice were inspected weekly for the development of skin tumors. All 12
homozygous Poll1 knockout mice (open diamonds) developed skin tumors by 18 weeks,
while all 12 Po 111+ Poll+ mice (open circles) developed skin tumors by 13 weeks. This

Polz-dependent decrease in tumor latency is highly significant (p<0.0002). No difference
was found in the histological analysis of skin tumors among the groups. Reproduced
with permission from Dumstorf C A et al. PNAS 2006; I 03: 18083-18088, Copyright
2006 National Academy of Sciences, USA.
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The role of Pol t in the induction of cancer induced by other carcinogens has not
been systematically studied to date. It is interesting to note that Newcomb et a/ found
that Polt-deficient 129 mice are resistant to y-irradiation-induced thymic lymphoma but
sensitive to methylating agent-induced thymic lymphoma [66]. y-Irradiation induces
DNA strand breaks and oxidative damage, and Polt is known to protect cells from
oxidative stress [67]. It is therefore possible that increased cell death after y-irradiation
protects PO/{I- 129 mice from lymphomagenesis. However, Polt does not affect the
sensitivity of Pol

~-null

cells to methylating agents [68], so the sensitivity of 129 mice to

thymic lymphoma induced in this way is still unexplained.
There is no known human disorder involving deficiency for Pol 1. However, Pol t
is overexpressed in some lung cancer cell lines [69] as well as in primary human gliomas
[18]. The T706A SNP was found to increase the risk of adenocarcinoma and squamous
cell carcinoma of the lung in persons <61 years of age [33]. However, this association
was not confirmed by another independent study [70] and failed to show significance in a
meta analysis [71]. Another SNP in human POLl, F532S, is associated with prostate
cancer patients whose tumors display TMPRSS2-ERG fusion with a highly significant
odds ratio of 4.6 [72]. The protooncogenic transcription factor ERG was identified as the
most frequently overexpressed gene in human prostate cancers [73], and fusion with the
androgen-responsive serine protease TMPRSS2 by chromosomal rearrangement was
found in >90% of ERG-overexpressing cases [74]. Threonine 706 and phenylalanine
532, the two residues altered by these SNPs in Polt, are located in the noncanonical
ubiquitin-binding motifs UBM2 and UBMl, respectively [75]. These two
polymorphisms could therefore affect binding of Pol t to ubiquitylated peNA, which is
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required for its recruitment to stalled replication forks following DNA damage. In the
case of prostate cancer, the F532S variant of Pol 1 may promote chromosomal instability
by causing replication fork stalling and double-strand break (DSB) formation. DSB
formed in this way could promote cellular transformation by causing chromosomal
rearrangements that place the proto oncogene ERG under control of the androgenresponsive promoter elements of TMPRSS2 and lead to ERG-overexpression as is found
in many prostate cancers [74]. Evidence supports the suppression of skin and lung
cancers by POll in humans and mice, and new studies suggest that other cancers could be
affected by this protein, making it a promising candidate for future investigation. This
dissertation focuses on the role of POll in cell cycle checkpoint regulation and
carcinogenesis after exposure to UV light.
POLK

The fourth member of the V-family is DNA polymerase K. Pol K performs
faithful TLS of BPDE-induced DNA damage in vitro by inserting de opposite a template
BPDE-adducted G [76,77,78]. Pol K is required for recovery from a novel BPDEinduced intra-S phase checkpoint, and the protein relocalizes to stalled replication forks
after BPDE-induced DNA damage [79,80]. PoIK-1- mouse embryonic fibroblasts (MEFs)
show persistent S-phase arrest after BPDE exposure, which results in increased DSB
formation at stalled replication forks and increased toxicity in cells without functional Pol
K

[80]. Avkin and colleagues measured TLS efficiency and fidelity in PoIK-1- MEFs using

a shuttle vector technique. TLS efficiency on a plasmid containing a site-specific BPDE2

1

N -dG adduct is reduced nearly threefold in PolK- - MEFs, and mutagenic TLS is

increased from 29% to 50% in knockout cells, supporting a role for Pol
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K

in the efficienct

and error-free bypass of BPDE DNA damage [81]. siRNA-mediated POLK-knockdown
also reduces the efficiency ofTLS past BPDE-N2 -dG in human U20S cells [82]. This
body of evidence suggests that Pol K could have an important role in cancers caused by
bulky chemical carcinogens like BPDE. Pol K has also recently been linked to nucleotide
excision repair. POIK-1- MEFs have reduced levels ofNER ofUV damage, including
reduced repair synthesis and removal of 6-4 photoproducts after UV. Both of these
phenotypes are largely corrected by expressing wild-type Pol K, but not a catalytically
inactive mutant [83]. Pol K carries out NER repair synthesis and is recruited to sites of
NER through its interaction with XRCCI and ubiquitylated PCNA [84]. These
remarkable studies highlight the ability of TLS polymerases to function in multiple
cellular pathways and the likelihood that POlK plays an important role in preventing DNA
damage-induced carcinogenesis. While PolK-knockout mice have been generated [85,86]
and show increased spontaneous mutagenesis in kidney, liver, and lung [87], no cancer
studies have yet been reported using these models.
Pol K is overexpressed in ~ 70% of non-small cell lung cancers (NSCLC)
examined [88], and this overexpression correlates with mutation status of TP53 [69]
which is itself an indicator of poor prognosis [89]. In addition, POLK promoter activity is
increased in TP53-/- cells, and p53 protein suppresses POLK promoter activity in vitro.
These reports suggest that Pol K overexpression in NSCLC could be secondary to loss of
functional p53, but the correlation between these two events must be investigated to rule
out an etiological role for Pol K in lung cancer. Much stronger epidemiological evidence
shows that Pol K is overexpressed in gliomas. Multivariate analysis indicates that Pol K
overexpression is an independent prognostic factor for the assessment of glioma patient
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outcomes (Fig. 1-4) [18]. Although the potential role of Pol K in the etiology of brain
tumors is unclear, Pol K is clearly a candidate for investigation of cancer risk and
chemoprevention of multiple tumor types.
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Fig. 1-4, Immunohistochemical analysis of Pol

K,

X 1110

X .j()f!

Pol t, and Pol 11 expression in primary

glioma tissues (G) and normal brain tissues (N). Paraffin-embedded tissue microarrays
comprising 104 primary glioma specimens from WHO grades I-IV were stained for Pol
K,

Pol t, or Pol11. Representative images of PolK, Pol t, and Pol11 expression: Aa, Ab, Ba,

Bb, Ca, and Cb, normal brain tissue; Ac, Ad, Bc, Bd, Cc, and Cd, pilocytic astrocytoma
(WHO grade I); Ae, Af, Be, Bf, Ce, and Cf, diffuse astrocytoma (WHO grade II); Ag,
Ah, Bg, Bh, Cg, and Ch, anaplastic astrocytomas (WHO grade III); Ai, Aj , Bi, Bj, Ci, and
Cj , glioblastoma multiforme (WHO grade IV); magnification: X100 (Aa, Ac, Ae, Ag, Ai,

Ba, Bc, Be, Bg, Bi, Ca, Cc, Ce, Cg, and Ci) and X400 (Ab, Ad, Af, Ah, Aj , Bb, Bd, Bf,
Bh, Bj , Cb, Cd, Cf, Ch, and Cj). Reproduced with permission from Wang et al. NE URO
ONCOL.2010 ; 12(7): 679-686; by permission of the Society for Neuro-Oncology.

Copyright 2010 Society for Neuro-Oncology.
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POLl;

The human homolog of yeast DNA Polymerase ~ is required for mutagenesis by
UV, BPDE, and other carcinogens [14,90]. Pol ~ belongs to the B-family of DNA
polymerases and contains a large catalytic subunit encoded by the REV3 gene in humans
[14] along with the much smaller regulatory protein REV7 [91). Early investigations in
Saccharomyces cerevisiae showed that rev3 mutant strains have reduced rates of

spontaneous mutation [92], indicating that Pol ~ is involved in the mutagenic processing
of spontaneous and UV-induced mutations. Studies in mammalian cells indicate Pol

~

has a role in both repair of double strand breaks and base substitution mutagenesis, the
latter likely involving extension of mispaired primer termini after initial TLS by another
polymerase [93,94]. Pol ~ is the only TLS polymerase required for development, and
complete Rev3-knockout results in mitotic catastrophe and lethality at mouse embryonic
day 10.5 [95,96,97). However, conditional Rev3-knockout mice have been generated and
are viable and fertile. While Rev3-deficiency alone is insufficient to promote cancer
formation, conditional Rev3 knockout accelerates the spontaneous formation of
lymphoma in Trp53-1- mice. In humans, REV3 gene expression is reduced by two-fold in
40 of74 (54%) colon carcinomas compared to matched normal tissue [98]. However,
normal expression is found in much smaller sample sets of gastric, colon, lung, and renal
cancers [99] and the gene is not mutated in primary tumors or cell lines from breast and
colon cancers [91]. The expression levels of REV3 in human cancers, particularly colon
carcinoma, must be revisited using larger sample sizes to draw firm conclusions about the
correlation of gene expression and cancer progression. No studies are published
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investigating the 25 nonsynonymous SNPS in human REV3, but the possibility exists that
functional changes in human Pol Scould alter the risk of cancer formation.
NUCLEOTIDE EXCISION REPAIR

Translesion synthesis is a mutagenic process that leaves intact lesions in DNA.
Most lesions which initiate TLS are removed from the genome by nucleotide excision
repair (NER), a process by which damaged bases such as CPD are enzymatically
removed as a part of an oligonucleotide fragment(comprehensive review in [100] (Fig IS). NER has two branches; global genomic-NER (GG-NER) describes the repair of
damage from transcriptionally silent areas of the genome, while transcription-coupled
NER (TC-NER) is dependent on the stalling of RNA polymerase II. The two branches of
NER differ in the mode of damage recognition. All lesions recognized by NER cause
local disturbances in the helical structure of DNA; this disturbance is recognized by the
XPC:RAD23B complex in GG-NER to initiate binding of the complex to the lesion site
in the DNA [101,102]. XPC acts to recruit TFIIH, a multi-subunit complex [103,104].
The next step in GG-NER is the formation of the preincision complex, which requires
recruitment of the scaffolding protein XPA, the endonuclease XPG, and the ssDNAbinding protein RP A [105]. XPD and XPB are A TP-dependent helicases contained in the
TFIIH complex confer single-strand character on a ~30 nucleotide region surrounding the
lesion [106]. The damaged lesion is pinpointed during formation of the preincision
complex, which allows XPG to be positioned and to cleave the damaged DNA stand 3' of
the lesion. The ERCCI-XPF complex is then recruited to excise the oligonucleotide
fragment by cleaving the damaged strand 5' of the lesion [107]. Repair synthesis then
fills the resulting single-strand DNA gap, and this step is performed by one of the
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replicative B-family polymerases, Pol 8 [108] or Pol

£

[109], or by Pol K as previously

discussed [84]. Finally, the patch is sealed by a DNA ligase [110].
TC-NER differs from GG-NER in the manner oflesion recognition, and was
discovered based on the observation that UV-induced CPD are removed from the highly
transcribed DHFR gene approximately 50-fold faster than a nearby untranscribed region
of the genome [111]. Stalling of RNA polymerase II causes recruitment of the SWIISNF
ATP-dependent chromatin remodeling complex CSB/RAD26 and rewinding of the
transcription bubble [112]. This promotes dissociation of the RNA polymerase and
identification of the lesion in the DNA template, at which point RP A, XP A, and TFIIH
are recruited to the lesion site to form the preincision complex, as in GG-NER.
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Fig. 1-5. Nucleotide excision repair (NER). Transcription coupled NER and global
genomic NER differ in the mechanism of lesion recognition, but share common excision
and repair synthesis proteins. Illustration kindly provided by Dr. 1. Christopher States,
University of Louisville.
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XPA-deficient cells have no residual NER activity [113], and XPA humans and
mice have dramatically increased risk ofUV-induced skin cancer [35,114]. XPA cells are
hypermutable due to deficiency in both TC-NER and GG-NER subpathways of excision
repair. Xpa- I - mice are used in UV carcinogenesis studies described in this dissertation
due to the advanced time line of cancer development in these animals.
CELL CYCLE CHECKPOINTS

Precise regulation of cell cycle progression is critical for maintenance of genomic
integrity for actively dividing cells. Cell cycle progression was originally proposed to
have a fixed timeline, but this theory was disproved when y-irradiation caused cell cycle
arrest proportional to the amount of DNA damage induced [115]. Eukaryotic cells
display G liS, G21M, intra-S, mitotic spindle, and postreplication checkpoints after
various types of DNA damage; the G21M and intra-S phase checkpoints are most relevant
to this dissertation.
Progression from G2 to M phase is regulated by the cyclin dependent kinase
CDK1, and DNA damage-induced arrest regulates the activity ofCDKl through a series
of phosphorylation events (Fig. 1-6). G2-arrest is maintained by the inhibitory
phosphorylation ofCDKl on Tyr15, catalyzed by the kinase WEEI [116,117]. CDK1 is
dephosphorylated at Tyr15 and activated to promote G2 -7 M progression by the dualspecificity phosphatase CDC25. CDC25C is regulated by sequestration in the cytoplasm
by 14-3-3 proteins. CHK1 kinase-mediated phosphorylation ofSer2160n CDC25C in the
nucleus promotes binding of 14-3-3 and nuclear export [118,119]. Polo-like kinase 1
(PLK1) is a master regulator of the G2/M checkpoint. PLK1 phosphorylates cyclin Bat
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Ser133 and Ser147 and promotes further activation of the CDC2/cyclin B complex to
promote mitotic entry [120,121]. WEEI kinase is regulated by destabilizing
phosphorylation by PLKI and CDC2 [122]. MYTl is another kinase responsible for
inhibitory Tyr 15 and Thr14 phosphorylation of CDC2, and MYTl is
hyperphosphorylated and deactivated by PLKI. PLKI also phosphorylates CDC25C in
the nuclear export signal to prevent its nuclear export in a l4-3-3-independent manner
[123].
The intra-S phase checkpoint is a p53-independent mechanism of arresting DNA
synthesis upon DNA damage. y-irradiation-induced DNA damage activates the sensor
kinase ATM, which in tum activates the effector kinase CHK2. Activated CHK2 then
phosphorylates CDC25A at Ser123 to promote the proteasomal degradation ofCDC25A.
Degradation of CDC25A, the regulatory phosphatase, for the G liS checkpoint leads to
sustained inhibitory phosphorylation of CD K2 at Tyr 15 and Thr 14 and persistent S-phase
arrest [124,125]. Translesion synthesis proteins are known to regulate the intra-S phase
checkpoint. While UV most strongly activates the p53-dependent G liS checkpoint in
normal cells, XP variant cells show a strong intra-S phase checkpoint [38,39]. While
new origins of replication fire at expected rates, replication fork progression is blocked at
sites ofUV-induced DNA damage. The absence ofPollj, the evolutionarily conserved
TLS polymerase for bypassing UV -induced DNA damage, prevents resolution of stalled
replication forks and leads to activation of the ATRlCHKl pathway [126]. BPDE also
induces an intra-S phase checkpoint [79,127], that is dependent upon the V-family Pol K.
A deficiency in this polymerase results in failure to recover from BPDE-induced S-phase
arrest and causes double strand breaks, likely due to collapse of stalled replication forks
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[80]. These studies show that TLS polymerase can directly impact cell cycle checkpoints
via their role in stabilizing stalled replication forks
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CONCLUSIONS

The importance of trans lesion DNA synthesis in preventing human cancer is well
understood from the example ofXP variant, in which patients lacking the V-family DNA
polymerase 11 are prone to develop UV -induced skin cancers due to an extremely
hypermutable phenotype. However, we understand very little about how the other
polymerases involved in TLS affect human health and cancer risk. Recently developed
mouse models have so far provided conflicting results; ribozyme-mediated knockdown of
total Rev 1 and removal ofthe BRCT domain both result in reduced mutagenesis by
BPDE or UV, respectively. As expected, when Rev} mRNA is knocked down using the
same ribozyme delivered to the lungs of mice, multiplicity ofB[a]P-induced lung
adenomas decreases [32]. In contrast, Revl BRCT-null mice develop UV-induced
squamous cell carcinomas faster than wild-type controls [20]. In a similarly paradoxical
finding, mice lacking both Pol 11 and POll have decreased UV -induced mutations in their
dermal fibroblasts and accelerated development of squamous cell carcinoma after UV
treatment compared to Poll-proficient animals [63]. While it is understood that the
mutations induced by these polymerases are etiological in many environmentally-induced
cancers, it is clear from these studies that simply blocking TLS is not sufficient to reduce
cancer risk, and in fact may cause an acceleration of carcinogenesis. One potential
explanation for these apparently contradictory findings is that TLS polymerases have
pleiotropic functions; DNA damage tolerance is the classic role, but they are also
involved in cell cycle checkpoint regulation [80], NER [84], and somatic hypermutation
[21]. Data presented in this dissertation indicate that POll is involved in regulating the
G2/M checkpoint after UV-induced DNA damage. These results suggest a novel role for
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Polland could explain the apparent tumor suppressor activity of POll seen in multiple
studies [63,64,66]
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CHAPTER II
CELL CYCLE CHECKPOINT REGULATION
INTRODUCTION
Translesion synthesis (TLS) is the direct synthesis of DNA across from a
damaged template and is performed by the Y-family of DNA polymerases [2]. These
specialized enzymes (PoITj, t,

K,

and REVI in higher eukaryotes) are recruited to stalled

replication forks due to blockage of the replicative DNA polymerases, POID and Pole, at
sites of DNA damage. Mammalian cells use TLS instead of more accurate damage
bypass mechanisms as much as 50% of the time to bypass replication-blocking lesions
[10,11,12]. The frequency ofTLS combined with its highly mutagenic potential make it
a critical target of study for cancer chemoprevention. PolTj catalyzes accurate TLS of the
most common CPD [41,42] and is defective in xeroderma pigmentosum (XP) variant
syndrome [43,128]. XP variant patients have extremely high risk ofUV-induced skin
cancer because their cells are extremely hypermutable upon UV exposure [40]. Pol

t

catalyzes inaccurate, error-prone TLS ofUV-induced DNA damage [129] and is at least
partially responsible for the high frequency ofUV-induced mutations in XP variant cells
[62,130]. We previously found that mouse cells lacking functional Poh have reduced
mutation frequencies after UV irradiation, but the loss of this error-prone DNA
polymerase accelerates tumorigenesis in PolTj-deficient mice [63]. Accelerated
tumorigenesis in
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Polr( Pol/- mice has been confirmed [64] and suggests that Pol t could participate in
UV -induced carcinogenesis outside of its role in TLS.
In addition to participation in DNA synthesis, V-family polymerases are known to
regulate cell cycle progression. The first known example was the pronounced intra-S
phase arrest observed in XP variant cells after UV irradiation [38,39]. Cells lacking Poll]
fire new origins of replication, but elongation of nascent strands is blocked due to
unresolved replication fork stalling. POlK has also been shown to regulate a distinct intraS phase checkpoint. After treatment with benzo[a]pyrene dihydrodiol epoxide (BPDE),

PoIK-/- MEFs fail to complete S phase at the rate of wild-type cells and display elevated
activation of ATM and Chk1 [80]. Other reports have shown that S. cerevisiae Rev1
protein levels are

~50- fold

higher in G2/M phase than in G 1 [131], and that disruption of

the BRCT domain ofRev1 in mouse cells causes G2 arrest after UV treatment [30].
These studies together suggest that V-family DNA polymerases can affect cell cycle
checkpoints after treatment with genotoxic agents. The experiments in this chapter were
designed to address the hypothesis that Pol t regulates cell cycle progression after UVinduced DNA damage.
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Materials and Methods
Cells and cell culture

Primary murine fibroblasts from Polr( and Pol/- mice were a generous gift from Raju
Kucherlapati (Harvard University) and were prepared as described previously [63] with
slight modifications. A piece of ear tissue was rinsed thoroughly in ethanol, then sterile
PBS, then finely minced in a 10 cm cell culture dish using two scalpels. The minced
tissue was allowed to sit for 10 minutes in a laminar flow hood with the dish lid cracked
for ~ 15 min to allow the tissue to adhere to the dish. Media was then gently added to the
dish to cover the surface of the tissue. Media consisted ofMEM-a (Cambrex Bioscience,
Walkersville, MD) supplemented with 10% FBS (HyClone, Logan, UT), 2 mM
glutamine, nonessential amino acids (Mediatech, Herndon, VA), penicillin (100
units/ml), and streptomycin (100 g/ml). Minced tissue was placed incubated for up to
three weeks under normoxic conditions at 37°C / 5% CO 2 /21 % O 2 and refed weekly.
Once cells reached confluence, tissue pieces were aspirated off and cells were designated
"passage zero" and split to a 15 cm dish. After passage zero was reached, all primary
mouse cells were incubated under hypoxic conditions (5% CO 2 /2% O 2 ) based on a
previous report that these cells have increased population doublings and time to
senescence under hypoxia [132]. For UV treatments, UV 254nm flux was measured using a
radiometer (model IL 1700; International Light, Peabody,MA). The average fluence was
~0.5 J/m2/s. Media was aspirated and cells were washed twice with PBS exposure to 4,

8, or 16 J/m 2 . SV40-transformed human fibroblasts (GM0637) were cultured in DMEM
(Cambrex Bioscience, Walkersville, MD) supplemented with 10% FBS (HyClone,
Logan, UT), 2 mM glutamine, penicillin (100 units/ml), and streptomycin (100 giml).
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mRNA expression
Total mRNA was isolated from cell culture plates on ice using the miRNeasy kit (Qiagen,
Valencia, CA), amplified, and resultant cDNA was transcribed using the GeneChip® IVT
Labeling Kit for hybridization on Affymetrix MOE 430_2.0 arrays using a GeneChip®
Scanner 3000 7G. A two-way ANOVA including interaction was used to detect
transcripts with significant interactions between cell line and treatment. An overall F-test
was used to determine which transcripts had at least one significant effect using the SAS
software package. An FDR cut-off of 0.1 was used for multiple testing correction,
followed by a cut-off for interaction p-value of 0.05 to produce a list of transcripts with a
statistically significant interaction effect. This interaction list was filtered to include only
transcripts with relative fold changes of> 1.5 or <-1.5 in either cell line. Statistical
analyses were performed in collaboration with the Bioinformatics, Biostatistics, and
Computational Biology core facility at the Center for Environmental Genomics and
Integrated Biology at UoiL.
microRNA expression
cDNA was generated and labeled, hybridized to microarrays, and scanned by LC
Sciences (Dallas, TX). Total RNA was isolated using the miRNeasy kit (Qiagen,
Valencia, CA) and enriched for transcripts <300nt using size fractionation after which
these transcripts were 3' extended with poly(A) polymerase and fluorescently labeled
with either Cy3 or Cy5. Hybridization of one Cy3- and one Cy5-labeled sample per chip
was followed by detection and quantification of fluorescence and as the Cy3/Cy5 ratio.
Microarrays were designed by LC Sciences and included redundant probes to detect all
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miRNA transcripts listed in Sanger miRBase 10.1. Data were analyzed by background
subtraction and LOWESS normalization, and a p-value cut-off of 0.05 was applied for
the t-test.
RT-qPCR
Confirmation ofmRNA and microRNA expression was performed by amplifying target
transcripts using specific primers and probes and a 7900HT Fast Real-Time PCR System
from Applied Biosystems (Foster City, CA). The

~~CT

method was used to measure

target mRNA or microRNA expression relative to GAPDH or snoRNA202, respectively.
microRNA target prediction:
Individual microRNAs determined to have significant expression changes after UV
treatment (p<0.05 by a t-test) were used as search terms for the miRanda microRNA
target prediction algorithm [133,134]. The list of predicted microRNA targets for each
genotype were intersected with the list ofUV-responsive mRNAs to produce a list of
filtered microRNA targets for each genotype.
Global pathway analysis
Three lists of mRNAs were analyzed using Ingenuity Pathway Analysis (Ingenuity
systems): interaction mRNA, Polr( Poll +/+ filtered microRNA targets, and Polrt Pol,-/filtered microRNA targets.
Immunoblots
For immunoblots, celllysates were prepared from trypsinized cell pellets with 10 mM tris
base pH 7.4,1 mM EDTA, 0.1% SDS, 180 J.lglml phenylmethanesulfonylfluoride).
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Twenty /lg whole cell lysate was separated on a 4-15% SDS-PAGE gel and transferred to
a PVDF membrane via electroblot using Towbin's transfer buffer (25 mM

tri~

base pH

8.3,192 mM glycine, 20% methanol, 0.02% sodium dodecyl sulfate), and analyzed with
the following antibodies: Weel (Millipore, 1:500), cyclin Bl (BD Pharmingen, 1: lOOO),
Cdkl (Millipore I: 1000), cyclin E (Abeam, 1:500), phospho-histone H3 (Cell Signal,
1: 1000), and

~-actin

(Sigma, 1: 10,000). All antibodies were diluted in 5% nonfat dry

milk and incubated overnight at 4°C.

Cell cycle analysis
Cells were pulse labeled for 30 min with 10 /lM BrdU (BD Pharmingen, San Diego, CA),
washed twice with PBS, and immediately UV irradiated. At 0,6, 12, 18,24, and 30
hours after UV, cells were trypsinized and collected for FACS analysis. Samples were
double-stained for BrdU and 7-aminoactinomycin D (7 AAD) using the FITC BrdU Flow
Kit (BD Pharmingen, San Diego, CA) following the manufacturer's instructions. FACS
analysis was performed on a FACScan flow cytometer (BD Biosciences, San Jose, CA).
Results were analyzed using FlowJo software.

Direct nuclear counting
Asynchronous cells were plated at 104 / cm2 and stained with giemsa the following day.
Stained cells were analyzed under 40X magnification. Two hundred cells per well were
counted for each genotype with three wells in total counted per experiment per genotype.
Three independent experiments were performed and results were analyzed using a single
factor ANOVA. Individual comparisons were made using the student's t-test.
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RESULTS

Polymerase iota deficiency alters the DNA damage response after UV treatment at the
transcriptional level
To detennine the effect of Poll-deficiency on the UV DNA damage response,
primary ear fibroblasts from Polr( Poll +/+ and Polr( Pol,-/- mice were irradiated with 4
J/m 2 UV, a dose which results in -30% survival [63]. Total RNA was harvested 24 hours

later and global microarrays were perfonned to analyze mRNA and micro RNA
expression profiles. There were 6,397 and 5,207 UV -responsive mRNAs in Polr(

Poll +/+ and Polr( Pol(/- cells, respectively. These transcripts all had fold changes> 1.5
or <-1.5 with p < 0.05 and q < 0.1. To statistically differentiate between these large lists
ofUV-responsive mRNAs and identify the transcriptional effect of Poll-knockout on the
UV DNA damage response, the interaction tenn was included in the two-way ANOV A
analysis ofUV treatment and genotype effect. In this statistical test, a significant
interaction tenn indicates that the UV -induced fold change of a particular mRNA was
different between the two cells trains. This analysis identified 484 mRNAs, tenned the
"Interaction mRNA" (Fig. 2-1), with a significant interaction between Polr( Poll+/+ and

Polr( Pol/- cells after UV treatment (p < 0.05, q < 0.1, fold change> l.5 or <-l.5).
UV-responsive miRNAs are shown in Fig. 2-2. Nine microRNAs were identified
in Pob( Poll +/+ cells and 11 microRNAs in Polr/ Pol,-/- cells with significant fold
changes after UV treatment (p < 0.05). Remarkably, the lists ofUV-responsive
microRNAs were mutually exclusive. To confinn the microarray results, two mRNAs
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Fig. 2-1. UV-induced mRNA expression changes in Polr/ Poll+1+ and Polr/ PoH1- cells.
Treatment with ultraviolet radiation altered expression of 6,397 genes in Polr/ Poll +1+
cells and 5,207 genes in Polr/ Pol(l- cells (p < 0.05, q < 0.1, and -1.5 > fold change >
1.5 in either genotype). A list of 484 transcripts showed a significant interaction effect
with p < 0.05 and q < 0.1. Results are from three replicate dishes from a single biological
experiment. The color key indicates normalized signal intensity values.
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Fig. 2-2. UV - induced microRNA expression changes in Polr{ Polt+l+ and Polr{ Pol ( 1cells. A t-test identified 9 microRNA in Polr/ Poh +/+ cells and 11 microRNA in Polr(

Pol/- cells that showed significantly altered expression after UV treatment (p < 0.05).
The two lists were mutually exclusive. Results are from three replicate dishes from a
single biological experiment.
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and two microRNAs were chosen at random from the lists of significantly altered
transcripts for RT-qPCR confirmation. As shown in Figure 2-3, micro array results for
mRNA and microRNA were reproducible with the exception of Ptprv increased in Polr/

Polz+/+ cells which could not be confirmed. We also found using RT-qPCR that miR-214
was slightly but significantly decreased in Polr/ Pol/- cells, which was not found using
the microarray platform.

Bioinformatics analysis indicates that Polz-deficiency alters the PLK pathway for mitotic
entry and exit
In order to combine mRNA and microRNA expression data, a bioinformatics
approach was used to identify the cellular pathway(s) affected by Pair-deficiency after
UV treatment. Figure 2-4 shows a schematic representation of the analyses performed.
The miRanda microRNA target prediction algorithm was used to computationally predict
mRNA targets of the 9 and 11 UV-responsive microRNAs in Polr/ Pair +/+ and Polr/

Polr-/- cells, respectively. This analysis yielded 8,519 predicted microRNA targets in
Pob(- Polr +/+ cells and 6,360 predicted targets in Polr( Po//- cells. To reduce the total
size and increase the biological relevance of the predicted microRNA targets dataset, the
list of predicted microRNA targets for each genotype was then intersected with the list of
UV -responsive mRNAs identified in the two-way ANOVA. In Polr( Polz +/+ cells, this
final filtered microRNA targets list contained 1,529 mRNAs, while 1,339 filtered
microRNA targets remained in Pob(- Pol/- cells.
Three lists of mRNAs were analyzed for global pathway enrichment using
Ingenuity Pathway Analysis (lPA). The 484 interaction mRNAs, 1,529 filtered Pob(
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Pob +/+ microRNA targets, and 1,339 filtered Polr( Pol(/- microRNA targets lists were
all analyzed using IPA and the results are presented in Fig. 2-5. The only canonical
pathway that was significantly enriched in all three lists was the PLK signaling pathway
for mitotic entry and exit. Of the 62 molecules that IP A lists in the pathway, the
interaction mRNA list contained 12/62 (p = 1.17E-9), the Poi1'( Poll +/+ filtered
microRNA targets list contained 10/62 (p = 1.48E-2), and the Polr( Pol(/- filtered
microRNA targets list contained 10/62 (p = 2.19E-3).
To more closely examine gene expression patterns in the PLK signaling pathway
for mitotic entry and exit, all genes listed in this pathway by IP A were downloaded and
analyzed in our mRNA dataset for expression patterns. Of the 70 genes listed by IPA in
the pathway, 31 were significantly altered in both Polr( Poh +/+ and Poll'/" Pol(/- cells (p
< 0.05, q < 0.1, and -1.5 > fold change> 1.5); the lists were not identical. Fig. 2-6 shows
the 10g2(fold change) ratios for all of the 37 genes that were altered in either genotype.
Twenty-seven of 37 (73 %) genes were increased in one or both genotypes; of these, 23
(85%) showed greater increase in Pol'!-/- Pob +/+ cells.
Loss of POll relieves a strong mitotic checkpoint in Pol'!-/- cells after UV
treatment.
In order to validate the bioinformatics analysis indicating altered mitotic
checkpoint activity with Pob-deficiency, cells were treated with 4 J/m2 UV and analyzed
for protein expression at 24 hours by western blot. Fig. 2-7 shows that in Pol'!-/- Poh +/+
cells, UV caused a modest increase in the G21M marker cyclin B 1. In contrast, cyclin B 1
levels were reduced after UV in Pol'!-/- Pol/- cells. The kinase WEEI was stable at 24
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molecules in the pathway were present on the interaction mRNA list (p= 1.17E-09), along
with 10 of 62 molecules on the filtered Polr( Polr +1+ microRNA targets list (p= 1.48E02), and 10 of 62 molecules on the filtered Pob( Po/(I- microRNA Targets (p= 2.19E03, 10/62 molecules).
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hours in Polrt Poll +/T cells but was reduced ~4-fold in Polr( Pol/- cells. CDKI levels
were unchanged in both genotypes examined.
To expand the scope of our analysis, cell cycle markers for G21M and G liS arrest
were analyzed by western blot in all four genotypes. Fig. 2-8 shows that in Polr( Poll +1+
cells, UV caused a strong increase in the mitotic marker histone H3 phospho-Serl 0
(phospho-H3). In contrast, phospho-H3 levels were reduced after UV in Polr( Pol(lcells. Levels of phospho-H3 were unchanged in wild type and Po 117 +1+ POl(l- cells.
Cyclin E, which is expressed at the G liS transition, was strongly reduced after UV in
wild type and Pol17-I - POl/l+ cells, while Pol17-I - Pol/- showed a strong increase in cyclin
E levels. Po 117 +1+ Pol(l- cells showed no change in cyclin E at the UV dose used.
Figure 2-9 shows bivariate FACS analysis of cell cycle progression in all four
genotypes after bromodeoxyuridine BrdU labeling and treatment with equitoxic UV
doses. All cells were pulse labeled with BrdU for 30 minutes to label actively the
replicating population. Immediately after pulse labeling, cells were UV treated. Wild
type and Po 117 +1+ POl(l- cells were treated with 8 Jlm 2 while Pol17-I- Poll +1+ and Pol17 -1-

Pol/- cells were treated with 4 Jlm 2 , doses that result in ~37% clonogenic survival [63].
To examine the behavior of cells in S phase at the time ofUV treatment, the BrdU(+)
population was gated and analyzed for cell cycle progression. After 18 hours,

~20%

of

BrdU (+) wild-type cells had completed S, G2, and M phases and were arrested in G I
phase. In contrast, only ~ I 0% of BrdU( +) Pol17 +1+ Pol/- cells completed the first
division at 18 hrs, and these numbers were unchanged at 30 hours. Both wild type and

Po 117 +1+ Pol(l- cells displayed functional G liS checkpoints as indicated by the absence of
cells entering S phase after UV treatment. In Pol17-I - Poll +1+ cells, the BrdU(+) population
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showed delayed S-phase progression; the G 1 population was 6% at 18 hours and 12% at
30 hours. BrdU( -) Pob( Poil +1+ cells did not arrest at the G liS border but progressed
into a very slow S phase and accumulated in G2/M. BrdU( -) cells in G 1 phase were
31 %, 18%, and 13% of total cells at 0, 18, and 30 hours, respectively. BrdU(+) Polr(

Pol/- cells were 7% G 1 at 18 hours and 2% G 1 at 30 hours. Double knockout cells
showed an increase in the number of polyploid cells which peaked at 18 hours and was
reduced at 30 hours. Accumulation of polyploid cells was most pronounced in Polr(

Pol,-I- cells, reaching 40% of total cells at 18 hours, versus ~20% in Pob(- Poll +1+ and
~IO%

in wild type.
To further investigate the apparent increased ploidy of Pol/- cells even before

UV treatment, all four genotypes of cells were stained with giemsa during asynchronous
exponential growth and nuclei were counted. The percentage ofbinucleated cells is
shown in Fig. 2-10. Loss of POll, both from the wild type and Polr( backgrounds,
resulted in a strong and significant increase in the number ofbinucleated cells. The
percentages ofbinucleated cells were 1.1 %, 5.6%, 2.0%, and 4.9% in wild type, Pol,-I-,

Polr(, and double knockout cells, respectively. The difference between wild type and
Polr( was also statistically significant, indicating that loss of Poll] also causes a slight
increase in the number ofbinucleated cells. We also examined the percentage of
binucleated cells in SV40-transformed human diploid fibroblasts (GM0637). The
GM0637 cell line displayed a low level ofbinucleated cells, two-fold lower that Polr(
cells and approximately five-fold lower than Po/z-I - and double knockout murine cells.
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Fig. 2-9. Pail-deficient cells display polyploidy after UV treatment. Wild type, Pair/"
Poll +1+, Pol1J +1+ Pol/-, and Pol1J-1- Pol( l- fibroblasts were pulse labeled with BrdU for 30
minutes immediately before UV treatment. Cells were irradiated with equitoxic UV

so

doses (811m 2 for wild type and Pol1J +1+ Pol/-; 411m 2 for Pol1J-I- Poll +1+, Pol1J-I- Pol(I-) and
collected at the indicated time points for BrdUI7 AAD multiparametric FACS analysis.
All cells showed active DNA synthesis of haploid populations as well as of polyploid
populations (>4n DNA content). After 18 hours,

~20%

of BrdU(+) wild-type cells had

completed S, G2, and M phases and were arrested in G 1 phase. Only ~ 10% of BrdU(+)
Pol1J +1+ Poll -1- cells completed the first division at 18 hrs, and these numbers were

unchanged at 30 hours. BrdU(+) Pol1J-I- Poll+ l + cells showed delayed S-phase
progression; the Gl population was 6% at 18 hours and 12% at 30 hours. BrdU(+) Pol1J1- Pol(l- cells were 7% G 1 at 18 hours and 2% G 1 at 30 hours. Double knockout cells

showed an increase in the number of polyploid cells which peaked at 18 hours and was
reduced at 30 hours.
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Discussion
Despite the fact that multiple reports have characterized Polt as a mutagenic TLS
polymerase in the bypass ofUV-induced DNA damage [62,63,129], Poll-deficiency has
been found by two independent groups to decrease the latency ofUV-induced
carcinogenesis in PollJ-1- mice [63,64]. These remarkable findings suggest that Pob could
playa novel role in the cellular response to UV -induced DNA damage, and to investigate
this possibility gene expression changes were examined after UV irradiation in PollJ-1-

Poll +1+ and PollJ-1- Pol/- primary murine ear fibroblasts. UV treatment caused significant
expression changes of thousands of mRNAs in both genotypes, and pathway analysis
indicated that these genes are in expected pathways including p53 and apoptotic
signaling. To more specifically identify the effect of Pob-deficiency, the two-way
ANOV A used to analyze the mRNA expression data included the interaction term. This
statistical test was chosen to parse out the common effects ofUV treatment on both
genotypes in order to identify the ways in which each cell type responds differently to
UV treatment. The 484 mRNAs with a significant interaction term (the "Interaction
mRNA") represent the mRNA expression signature of Poll and can be exploited to
determine which cellular pathways are perturbed after UV treatment by the loss of Pob.
UV irradiation was also found to affect microRNA expression, and this was also
directly impacted by Poll-deficiency. Nine and 11 microRNAs were identified in PollJ-1-

Pob +1+ and PollJ-1- Pol/- cells, respectively, as having significant UV -induced changes.
These two lists of microRNAs were mutually exclusive, indicating a complete divergence
of the microRNA response to UV-induced DNA damage concomitant with Polldeficiency. UV-responsive microRNA have been identified in mammalian cells [135]
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and linked to the DNA damage response [136]. However, our list ofUV-responsive
microRNA shows little overlap with previously published reports. Since the cells used in
this study are derived from nonisogenic mice as described [63] (Polr( Pob +/+ = C58Bl/6;

Pob(- Po/(/- = hybrid C57B1I6 X 129 X B6 background from an F2 generation
backcross), we chose to use high stringency statistical cutoffs and multiple methods of
analysis for the expression data. The nonisogenic nature of the cell strains used does
raise the possibility that the gene expression results we obtained are actually attributable
to strain differences rather than to loss of Pol 1. It is for this reason we used strict
statistical cutoffs followed by biological validation of the microarray results.
Fig. 2-4 illustrates how mRNA and microRNA expression datasets were analyzed
using statistical and bioinformatics tools to formulate lists of mRNAs that represent the
"signature" of Poll in the UV DNA damage response. These lists ofmRNAs can then be
analyzed for pathway enrichment to identify novel candidate pathways modulated by Poll
after UV. As described, the Interaction mRNA list was derived directly from mRNA
microarray data using a two-way ANOVA. The interaction term was utilized in this
ANOVA to remove the common gene expression patterns ofUV-response between the
genotypes. In order to have a significant interaction term, a particular mRNA must show
different fold changes after UV between the two genotypes; thus, the interaction test is
one way to distinguish unique gene expression patterns due to the loss of Poll. To
analyze the microRNA expression data for pathway enrichment, the miRanda target
prediction algorithm was used to generate putative mRNA target lists for the UVresponsive microRNAs from each genotype [133,134]. Target predictions from miRanda
are based on partial or complete complementarity of the microRNA with the 3' UTR of
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the target mRNA. Importantly, because of the computational nature of the target
prediction method used, several hundred mRNAs were returned as putative targets of
each UV -responsive microRNA. This generated very large lists of predicted microRNA
targets which were expected to contain a high percentage of false positives due to
inaccurate algorithm predictions, estimated to be as high as 34% [133]. For each
genotype, the list of predicted microRNA targets was intersected with the list ofUVresponsive mRNAs to generate the list of "Filtered microRNA Targets." This method of
filtering the predicted microRNA targets list was used to reduce list size and eliminate
false positives. All mRNAs included on the final list of Filtered microRNA Targets in
each genotype met two criteria; first, each mRNA was predicted to be the target of at
least one UV-responsive microRNA from that genotype, and second, each mRNA was
itself significantly altered by UV treatment. This final filtering step reduced by ~5-fold
the number of microRNA targets for each genotype to 1,529 in Polr/ Polz +/+ cells and
1,339 in Pob( Pol(/- cells.
Ingenuity Pathway Analysis (IPA) was used to analyze three lists ofmRNAs:
Interaction mRNA, Filtered Pob( Polz +/+ microRNA Targets, and Filtered Pob( Pol/microRNA Targets. These three lists were taken to represent the signature of Poh in the
UV DNA damage response, and global pathway analysis revealed the enrichment of only
one canonical pathway shared among the three datasets. The PLK signaling pathway for
mitotic entry and exit was significantly enriched in all three mRNA lists analyzed,
indicating that deficiency in Poh alters cellular responses to UV damage through this
pathway.
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To validate the dysregulation of the G2/M checkpoint after Polz loss, cell cycle
markers were analyzed by immunoblotting. Accumulation ofphospho-H3 and cyclin BI
24 hours after 4 J/m 2 UV indicates that Pob( Polz +/+ cells accumulate in G21M in
response to UV -induced DNA damage (Fig. 2-7 and 2-8). Apparent activation of this
checkpoint coincides with a reduction in levels of the G liS marker, cyclin E, as expected.
The UV-induced accumulation of mitotic markers was reversed in Polr( Pol/- cells,
providing evidence that expression ofPoh is required for activation of the G21M
checkpoint seen in Pob( Polr +/+ cells. Cyclin E expression was increased in double
knockouts 24 hours after treatment, indicating that cells accumulated at the G liS
boundary. While WEEI levels were stable in Pob( Pol//+ cells, double knockouts
showed a strong reduction in WEEI after UV treatment. WEEI phosphorylates and
inactivates CDKI and is a target of PLKI for phosphorylation and subsequent
degradation. Reduced levels of WEE I in Polr( Pol(/- cells could indicate increased
PLKI activity, supporting our finding that the PLKI pathway is dysregulated by Poh
deficiency. Cyclin E levels were reduced after UV in wild type cells, but stable in
Po 117 +/+ Polz -/- cells. This change in the response of the G 1IS marker could be explained

if Po 117 +/+ Po/(/- underwent endoreduplication and did not divide in order to arrest at
G liS, as our hypothesis would predict.
To specifically address cell cycle kinetic changes after UV treatment, we
examined 7AAD staining of BrdU-Iabeled cells. In order to label the S phase popUlation
of all four genotypes immediately before UV treatment, all cells were incubated with
BrdU for 30 minutes and then treated with equitoxic UV doses (Fig. 2-9). This
experimental design allows one to gate the BrdU (+) population of cells, those that were
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in S phase immediately before UV treatment, and follow that population over time to
examine Sand G2/M exit. Conversely, one can also follow the BrdU(-) population to
examine rates of entry into S phase after UV. All four genotypes displayed appreciable
replication of polyploid cells, indicating the presence of a stable population of cells with
DNA content >4n. BrdU(+)PollJ +1+ Pol/- cells exited mitosis more slowly than wild type
cells; at 18 hours only 10% of PollJ +1+ Pol(l- cells had completed the first cell cycle
compared to 20% of wild type cells. Both genotypes displayed a functional G liS
checkpoint as indicated by the lack of BrdU( -) G 1 cell migration into S phase. The
finding that Poh-deficiency causes G2/M accumulation in wild-type cells conflicts with
our previous findings that loss of Poh causes alleviation of the mitotic checkpoint in
PollJ-1- cells (Fig. 2-9).

There was significant intra-S phase arrest in PollJ-1- Poh +1+ cells as expected;
BrdU(+) G 1 peaked at 12% 30 hours after UV treatment. In addition, these cells did not
arrest at G liS but instead proceeded into a very slow S phase and arrested in the G2/M
compartment. BrdU(-) PO!IJ-1- Pol/1+ cells decreased from 31 % to 13% of total cells over
30 hours, indicating a mitotic block which prevented division of these BrdU(-) cells.
Strong intra-S phase arrest in this genotype was expected [38,39], but the accumulation
of cells in the G21M compartment at this late time point is a novel finding to our
knowledge. BrdU( -) PollJ-1- Pol(l- cells displayed a normal G liS checkpoint and did not
proceed en masse into S phase as the PollJ-1- Po!r+I + cells had done, indicating that loss of
both polymerases reactivates the G 1IS checkpoint. BrdU (+) PollJ -1- Poh -1- cells did not
divide and return to G 1, but instead underwent endoreduplication. Levels of polyploid
cells were highest in the double knockouts, and peaked at 40% 18 hours after UV
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treatment. This finding supports our hypothesis that POll modulates the mitotic
checkpoint and our previous data that loss of Polz relieves a mitotic checkpoint.
Our FACS analysis indicated that a mitotic checkpoint was not activated in Pol/cells, allowing them to complete mitosis without dividing and enter a tetraploid state. To
directly support this hypothesis, we stained asynchronous cultures of cells with giemsa
and counted mono- and binucleated cells (Fig. 2-10). We found that loss of POll
increased the percentage ofbinucleated cells by more than two fold. These data support
our hypothesis that Pol 1 is involved in activation of the mitotic checkpoint, and in its
absence checkpoint failure leads to the accumulation of endoreduplicated cells. We did
not a slight but significant increase in the percentage ofbinucleated cells in the Polr(
genotype. We did not find evidence of increased tetraploidy in Poll)-deficient cells via
FACS analysis; nevertheless, direct analysis of the nuclei indicates that Poll) could also
playa role in regulating the mitotic checkpoint
The phenotype of increased tetraploidy we observed in Pol/- mouse fibroblasts is
relevant to human cells, particularly to transformation by simian virus 40. Typically,
human cells are not permissive of a tetraploid state; anything that induces tetraploidy
causes death of the cell population via a p53-dependent postmitotic checkpoint [137].
However, SV40 infection blocks the activity ofp53 and promotes the gradual
accumulation of a tetraploid population very similar to that seen in Poll-deficient cells
[138]. This is an important finding as it indicates that POll deficiency could be an
unidentified human health concern.
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Results presented in this chapter support the hypothesis that Pol 1 regulates the
mitotic checkpoint, though the exact nature of the regulation appears to depend upon the
cells' ability to tolerate UV-induced DNA damage. Our gene expression analyses were
done using Polr/ cells, which lack the major TLS polymerase for accurate bypass ofUV
damage and rely on Poll to complete mutagenic TLS and, in theory, prevent DSB and
genetic instability. Our results indicated that loss of Poll promotes endoreduplication,
allowing mitotic completion and blocking cytokinesis. This finding was supported by
cell cycle kinetics, which showed that Polr( Polz +/+ cells in S phase at the time of UV
treatment slowly complete Sand G2 and divide. Loss of Poll causes cells to bypass
division and endoreduplicate, indicating they have bypassed the spindle assembly
checkpoint in M phase and entered a tetraploid state. In wild type cells replicating DNA
during UV treatment, loss of Polz causes a reduced rate of division after UV. This is
likely caused by an activated mitotic checkpoint in Polrt +/+ Pol/- cells, in contrast to our
findings in Polrt-/- cells. This difference in response is likely due to the major role in UV
DNA damage tolerance played by Pol 11; in the presence of Pol 11, Poll plays only a
minor catalytic role in TLS at the replication fork. In the absence of Pol 11 (XP variant),
cells rely on Pol 1 to perform TLS across from UV lesions. It is possible that Pol 1 is
required to signal G2 arrest for postreplication repair, when TLS is performed in G2
phase after semiconservative DNA synthesis has left single-strand gaps in DNA across
from lesions. Loss of Poll could fail to trigger this checkpoint and allow a cell with
numerous ssDNA gaps to proceed through G2 and M phases and undergo recombination
or endoreduplication.
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CHAPTER III
UV CARCINOGENESIS
INTRODUCTION
Ultraviolet radiation (UV) is the most ubiquitous environmental carcinogen and is
clearly linked to the etiology of skin cancer in humans [139]. The UV spectrum is
divided into low-energy UVA (320-400 nm), mid-range UVB (295-320 nm), and highenergy uve (100-295 nm). Wavelengths below 300 nm are completely filtered out by
ozone in the atmosphere between 10 and 50 km above the earth's surface, along with a
large portion of the UVB component of solar radiation [140](Fig 3-1). While only 10%
of the UV radiation reaching the earth's surface is UVB, this component is still the major
cause of sunburn and skin cancer. UV wavelengths of -295 nm (UVB) are -1O,OOO-fold
more potent in causing cancer that those> 340 nm (UVA) [141 ](Fig 3-2). UV exposure
acts as a complete carcinogen; the DNA damage induced by higher energy UVB rays
causes mutations in protooncogenes and tumor suppressors [139,142], and long-term
exposure causes immunosuppression and tumor promotion [143]. Human exposure
levels are typically measured in terms of the minimal erythema dose (MED) for the skin
type being exposed. For a person with skin type I ("always bums, never tans"), the MED
is 200 J/m2 . Over the Fourth ofJuly weekend in 2010, maximum UV fluxes achieved,
measured in the range of 300-400 nm, were 24
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uve and some UVB

wavelengths are filtered by ozone in the atmosphere. UVB is primarily responsible for
UV-induced cancer, while UV A is primarily responsible for photoaging. Adapted with
permission from Fiedberg et al [100].
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Fig. 3-2. Skin Cancer Utrecht-Philadelphia (SCUP) action spectrum for hairless albino
mice. Data were collected from 14 UV sources and about 1100 mice to generate an
action spectrum for the induction of skin cancer by UV light in mice. Adapted from de
Gruij 1, Cancer Res 1993 [141] with permission.
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2

2

J/m *min in Waimea, Hawaii, 18 J/m *min in Homestead, Florida, and 15 J/m *min in

West Lafayette, Indiana [144]. At these levels of exposure, it would take as little as eight
minutes for sun damage to occur to unprotected skin of type I. In vivo studies of
photocarcinogenesis utilize sub erythemal doses of UV to avoid the massive stimulation
of the immune system triggered by the sunburn response. In this dissertation, the daily
doses of 50 J/m2 UVB were approximately 20-fold lower than the MED of the animals
being treated.
It is important to note that most studies of cells in culture, including those in this

dissertation, make use of high-energy UVC lamps with emission peaks at 254 nm due to
the high efficiency of absorption of DNA (260 nm absorption peak). Despite the fact that
this exposure is not physiologically relevant, 254 nm UVC radiation is highly specific for
inducing DNA damage and is therefore an ideal genotoxicant for DNA repair studies. In
addition, the true environmental carcinogen UVB also induces 6-4 photoproducts and
CPDs in the same relative frequency as UVC, although with less efficiency [65,145].
Evidence also shows that UVC can generate the oxidate damage that is the hallmark of
UVA exposure and thought to lead to the phenomenon of skin ageing, although with a
different frequency [146]. Thus, while treating cells in culture with UVC is not
physiologically relevant, this genotoxicant is chosen as a precision tool to induce almost
exclusively damage to the DNA, and results obtained from these studies must be
considered in that context.
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NONMELANOMA SKIN CANCER

Skin cancer is divided into two basic categories: melanoma and nonmelanoma
skin cancer (NMSC). NMSC is the most prevalent cancer in the world and is further
divided into basal cell carcinoma and squamous cell carcinoma (SCC). More than six
million cases of nonmelanoma skin cancer were diagnosed in the US in 2006, and the
number of cases continues to rise annually [147,148]. Up to one-fifth of seventy-yearolds have had at least one NMSC diagnosis [149]. Despite the low mortality of the
disease, it still poses a significant public health burden due to the number of affected
individuals. Direct costs attributable to NMSC treatment in the US were nearly $1.5
billion in 2004 and are primarily made up by office visits for outpatient surgeries [150].
Pol t is implicated in error-prone TLS ofUV-induced DNA damage in
vivo. While Pol11-deficient mice develop cancer rapidly due to high UV -induced

mutation frequencies, loss of Pol t causes both a reduction in cancer latency and mutation
frequency [62,63,64]. This remarkable finding indicates that Pol t could have a role
outside ofTLS, but the conclusion is limited due to the fact that the phenotype was only
observed with concurrent deletion of Pol 11. The studies in this chapter were designed to
address the hypothesis that Pol t deficiency decreases UV-induced tumor latency.

64

Materials and Methods

Mouse Model
All animal studies were approved by the Institutional Animal Care and Use Committee at
the University of Louisville. Pol/- 129/SvJ mice [59] were purchased from Jackson
Laboratories (Bar Harbor, Maine), and PollJ-1- mice [19] were a gift from Raju
Kucherlapati (Harvard University). SKHlIhairless Xpa- I - mice [151] were a gift from
Harry van Steeg (Leiden University Medical Centre). PollJ-1- and Pol(l- 129/SvJ mice
were each backcrossed for seven generations with SKHlIhairless Xpa- I - mice. Resultant
isogenic genotypes were Xpa- I- PollJ +1+ Poll +1+ controls, Xpa- I- PollJ-1- Poll +1+, and Xpa- I1I +1+ P01P OIJ
1.

UV Irradiation
Mice were irradiated with a bank of two UVM-225D bulbs with peak emission at 302 nm
(UVP, Upland CA). UV flux was measured using an IL1700 radiometer with a UVB-l
sensor fitted with a WI diffuser (International Light, Peabody, Massachusetts). The
sensor measures the output at 313 nm. Mice were irradiated with 50 J/m2 five days per
week for 12 weeks and monitored for tumor growth twice weekly. This dose is well
below the MED of -1,000 J/m2 . Animals were euthanized 20 weeks after the start ofUV
or when one tumor reached> 10% of body mass. The animals were photographed and
skin tumors were dissected, formalin fixed, paraffin embedded, and sectioned for
histological analysis.
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RESULTS
Xpa- I - mice developed tumors with 100% penetrance and short latency, with all

mice bearing one tumor by 15 weeks after UV treatment started (Fig. 3-3). Xpa- I - Polr(
mice developed cancer faster than Poill-proficient controls, with all mice bearing at least
one tumor by 12 weeks (p < 0.01). Xpa-I - Pol(l- mice all had one tumor by 13.6 weeks, a
reduction in tumor latency that that trended towards significance (p = 0.057). This is the
first time that loss ofPolt as the only TLS polymerase has been shown to reduce UVinduced tumor latency.
Histopathological analysis revealed no distinct differences among genotypes of
mice (n = 10 tumors per genotype, Fig. 3-4). All tumors analyzed were Sec. We did not
observe the highly aggressive spindle cell tumors in Poh- I - mice reported by others [64].
Our finding of only see in all genotypes is consistent with the work of Dumstorf et al
[63].
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Fig. 3-3. UV-induced carcinogenesis in Xpa-I - mice. Kaplan-Meier plot induced by 12
weeks of treatment with 50 J/m2 five days per week. Survival is defined as the fraction of
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Fig. 3-4. Histopathology of squamous cell carcinoma in Xpa-I - mice. Ten tumors from
each genotype were sectioned and stained with H&E for blinded pathological analysis.
All tumors were locally invasive squamous cell carcinoma.
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DISCUSSION
It is well known that loss of Pol 11 results in dramatically reduced UV-induced

skin cancer latency in humans [35] and mice [19]. Pol 11 appears to be evolutionarily
conserved [13] to perform accurate bypass ofUV-induced DNA damage [41,42,43,128],
but much less is known about the effect of the error-prone POll in animals. We have
demonstrated that loss of POll causes a trend toward decreased tumor latency (Fig 2-3).
This was an intermediate phenotype compared to the Polr( mice. These studies support
our hypothesis that POll suppresses formation ofUV-induced skin cancer, This
hypothesis was based on the previous finding that Polr( Pol/- double knockout mice
develop tumors faster than Pob( Poll +1+ mice, despite reduced UV-induced mutation
frequencies in Pol,,-I- cells [63].
The reason we did not find a significant difference between Xpa- I- and Xpa- I- Pol(
1-

mice is possibly due to the small effect sizes that result from the Xpa- I- background.

C57B1I6 mice are resistant to UV -induced skin cancer, and wild type animals usually do
not develop tumors even after months of chronic UV exposure [19]. It is for this reason
that previous studies could not assess the effect of Poll-1- on UV carcinogenesis; neither
wild-type nor Pol(l- mice developed tumors [63]. We backcrossed Pol,,-I- and Pol/- into
the SKHlIhairlessXpa-l - background, which is highly susceptible to UV-induced SCC
[151]. As a result, the difference in tumor latency between the control and experimental
groups is very small. It is also possible that the severe phenotype of complete NERdeficiency in the Xpa-I - controls partially masks the phenotype of POll knockout. Using
Xpa-wild type mice, which develop tumors after approximately 20 weeks of chronic UV

treatment, as controls could increase the effect size of Po 1(1- knockout and the
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significance of the difference between groups. It is also possible that we did not have
significant numbers of mice per group to detect a significant difference. We did perform
a power analysis in collaboration with the Statistical Consulting Center at the University
of Louisville School of Medicine, estimating an effect size based on previous data from
our lab [63]. We determined that a sample size of28 mice per group would provide 80%
power for pairwise two-sided log rank test to detect differences in tumor latency at a
significance of 0.05. Based on the smaller effect sizes in this study and the fact that our
control and Xpa -1- Pob( group were under-populated, it is possible that increasing the
number of mice in these groups, or all three groups would bring the p-value below 0.05.
Our histopathological analysis indicated that Polrt and PO/{I- mice develop the
same locally invasive SCC as Xpa- I- control mice. This finding is in agreement with a
previous report from Dumstorf et al [63], but conflicts with the findings of aggressive
spindle cell tumors in Pol/- mice found by Ohkumo et al [64]. One possible explanation
of the discrepancy among findings of tumor pathology in these studies is the background
of the mice used; Ohkumo et al used isogenic Polr( and Pol/- mice in a C57Bl/6
background [64], and mice in this study were isogenic in the SKHlIhairless Xpa- Ibackground. Dumstorf et al used mixed backgrounds for carcinogenesis studies. Wild
type and PollJ-1- mice were C57B1I6, and Pol(l- mice were 129 background. Double
knockout mice were in a hybrid C57B1I6 X 129 X B6 background from an F2 generation
backcross [63]. The spindle cell tumors were only observed in Po/z-I - mice [64], which
were in a C57B1I6 background in that study. The fact that Pol/- mice are in different
backgrounds in both this study and in Dumstorf et al is a confounding factor in
comparing the results of these three carcinogenesis studies.
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We also carefully examined all tumors for the presence of multinucleated cells.
Based on our findings of increased binucleated cells in the Pol/- genotype (Fig. 2-10),
we expected that tumors from Xpa- I- Pol,-I- mice would exhibit binucleated cells. The fact
that we did not find evidence ofbinucleated cells or multinucleated tumor giant cells
could be a result of the long period of time between tumor initiation and histopathological
analysis (as long as 15 weeks for Xpa- I- Polr(- andXpa-l - Pol/- mice). Also, our studies
in Chapter II were also based on primary fibroblasts in culture, whereas the tumors
analyzed in this study are epithelial in origin. It is possible that the POll has a cell-type
specific role in regulating cytokinesis; however, we also analyzed fibroblasts in the
basement membrane below the tumors and found no evidence ofbinucleated or
multinucleated cells. Another possible explanation is the strain of the mice used, since
cells used in Chapter II were isolated from the mixed background mice described in
Dumstorf et al [63]. Strain differences are a confounding factor when comparing the cell
culture studies that showed impaired cytokinesis in Pol,-I- cells and in vivo studies with
isogenic SKHl/hairless Xpa- I - mice which did not confirm these findings. More direct
studies are needed to address the role of Pol 1 in regulating cytokinesis in live animals,
but this study does support our hypothesis that POll suppresses UV -induced
carcinogenesis by showing a trend towards decreased tumor latency in Pol/- mice.
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CHAPTER IV
BPDE MUTAGENESIS
INTRODUCTION
Mutagenesis is a recognized cornerstone of every form of human cancer [152]
dating back to the discovery of aneuploidy in cancer cells [153]. According to the
modem somatic mutation hypothesis of cancer, a cell must undergo several independent
genetic and epigenetic events that together confer properties associated with the
malignant phenotype. These include acquisition of infinite lifespan, resistance to
apoptotic signals, growth factor independence, resistance to anti growth signals,
angiogenesis, and tissue invasion [1]. Acknowledgment of the critical role of mutations
in carcinogenesis opens the possibility of chemoprevention using antimutator strategies.
Although recent advances have elucidated key details of the pathways underlying
mutagenesis, there exist critical gaps in our knowledge of the fundamental mechanisms
by which DNA is mutated during carcinogenesis. In this thesis, we will investigate how
environmental carcinogens permanently alter the sequence of DNA in order to cause
cancer.
Benzo[a]pyrene (B[a]P) is also a well-studied skin carcinogen. It is clear that
anti-benzo[a]pyrene-7,8-diol-9,1 O-epoxide (BPDE), a metabolic derivative ofB[a]P, is
the ultimate carcinogen [154,155]. BPDE formation proceeds through the action of
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CYP450, microsomal epoxide hydratase, and repeated CYP450 oxidation (reviewed in
[156]). Carcinogenic activity ofB[a]P is primarily due to in vivo binding of the ultimate
carcinogen to DNA to form bulky adducts [155]. As analyzed by 32P-postlabeling,
stable BPDE-N2-dG adducts constitute over 98% of adducts formed in mouse skin
treated with anti-BPDE [157]. However, other reports indicate that multiple other
adducts are formed by B[a]P in mouse skin and may be at a higher frequency than 2%
[158,159]. These adducts are normally recognized and repaired by enzymes in the NER
pathway. Purified Pol 1'] and Pol t perform well-characterized error-prone bypass of
BPDE lesions in vitro [77J, but this chapter is designed to address the hypothesis that
these enzymes are involved in mutagenic bypass ofBPDE-induced DNA lesions in living
cells.
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METHODS
Cell culture
Poly! knockout mice were recently generated by our collaborators in a C57Bl/6 hybrid

background [19]. To generate polrl-I-poh-I- double knockouts, these animals were bred
with 129/0la mice, which have been shown to carry a nonsense mutation in poh resulting
in a protein truncated at Ser-27 [59]. Primary fibroblasts have been isolated from these
mice and used for mutagenesis studies in our laboratory [63], and these cells were used in
this Chapter. Mouse fibroblasts were grown in monolayer cultures using a-MEM
supplemented with non-essential amino acids, penicillin-streptomycin and 10% fetal
bovine serum. They were maintained in exponential growth. We routinely grow primary
murine cells in a 3% 02/5% C02/92% N2 atmosphere [132].
Hprt mutagenesis

For genotoxicant treatment, cells were plated at 1 x 104 cm-2 . The culture media was
removed and cells were washed twice with sterile phosphate-buffered saline (PBS, pH
7.4). Serum-free media was added to the cells along with each chemical carcinogen for a
period of one hour. We used 150 nM BPDE for survival and mutagenesis studies. After
one hour of treatment, the culture media was aspirated followed by two washes in PBS.
For cytotoxicity, cells were trypsinized and counted, then replated at cloning density (the
exact number depends on the expected survival). After two weeks, plates were stained
with 1% crystal violet and counted. For mutagenesis, cells were maintained in
exponential growth for eight days after treatment, after which we trypsinized, counted,
and selected I X 106 cells with 20 /lM 6-thioguanine at a density of 3000 cm-2 . After 2
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weeks of selection, we isolated individual TG T clones, trypsinized, and resuspended them
in RNase-free PBS. The technique for amplifying the hprt gene was performed as
described [160] with modifications routine in our laboratory [90]. Briefly, TGr colonies
were pelleted at 4°C and the PBS removed. The cells were directly lysed and cDNA
generated using a cDNA cocktail. After incubation at 37°C for 1 h amplification was
performed using a Taq polymerase cocktail and two outer primers. The 5' primer is from
position -47 to -28 relative to the start codon (GGC TTC CTC CTC AGA CCG CT). The
3' primer is from position 790 to 771 (ACA TCA ACA GGA CTC CTC GT).
Reamplification using an inner primer set (5', from -27 to -8, TTT TGC CGC GAG CCG
ACC GG and 3', from 770 to 751, ATT TGC AGA TTC AAC TTG CG) will follow. The
PCR products were sequenced with each of the inner primers using an ABI 370
automated DNA sequencer and dRhodamine dye terminator chemistry.
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RESULTS
Fig. 4-1 shows clonogenic survival of wild type; Polr( Polz +1+, PolY/ +1+ Po 1/-,
and Poly/-I- Pol/- cells treated with 150 nM BPDE. There were no differences in BPDEinduced cytotoxicity. Hprt-induced mutation frequencies are shown in Fig. 4-2. Loss of
Pol 11 or Pol 1 alone reduced mutation frequencies by ~80%; double knockout cells
displayed mutation frequencies similar to those of the single knockouts. Mutation
frequencies were 191,34,44, and 56 TGT mutants per 106 clonable cells in wild type,

Poly/-I-, Pol/-, and double knockout cells, respectively. These data support our
hypothesis that POll participates in error-prone TLS of BPDE-induced lesions, probably
in coordination with Pol 11 due to the similar phenotype of the Pol 11-knockout and the fact
that the double knockout cells have the same mutation frequency. Table 4-1 summarizes
T

Hprt sequencing data from TG clones. These data indicate that the polymerase
responsible for making mutations opposite the bulky BPDE-DNA lesion in both wild
type and POly/-I- cells has a similar mutation spectrum. The percentage of frequent

uv-

induced mutations such as C--+ T transitions and G--+ T transversions were very similar
between genotypes despite the dramatic reduction in the mutation frequency in POly/-Icells. However, tandem mutations (10.5%) were only found in the wild type cells, and
small deletions (5.6%) were only found in Polr( cells. The number ofTGT clones
analyzes was insufficient for statistical analysis. Due to consistently low replating
efficiency, insufficient clones could be isolated from PolY/ +1+ POl,-l- and POly/-I- Poll- I- cells
for analysis.
Table 4-2 lists the mutant Hprt sequences from TG T clones. Specific analysis of
the sequence data reveals similar distribution of mutations throughout the Hprt gene. We
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did find that the only mutations arising from adducts in the transcribed strand were in
wild type cells (3 of 19).
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Fig. 4-1. Loss of Pol 11 or Pol t does not affect BPDE-induced cytotoxicity. Primary
dermal fibroblasts isolated from mice of the indicated genotypes were treated with 150
nM BPDE at 104 cm-2 and immediately replated at cloning density. Cells were refed after

seven days and stained with crystal violet after 14 days to determine clonogenic survial.
There were no significant differences in clonogenic survival among the genotypes.
Average survivals were calculated based on results from at least four independent
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VVjld Type

rJlutation Type
Transitions
A-T - G·C
G·e - A·T
Trans"ersions
A-T - e -G
A-T - T-A
G·C - T-A
G·C - C·G
Tandem
Small Deletion
Total

Pol!,}--Independen Percent of Independent Percent of
Clones
Total
Total
Clones

21 1
53

~

1
3
13
2
1
10
0
2
0
19

158
68 4
105

53
526
00
105
00
1000

5
2
3
12
0
0
11
1

0
1
18

2 8
11 1
16 7

667
00
00
61 1
56
00

56
100 0

Table 4-1. Summary of BPDE-induced mutations. Isolation and sequencing of Hprt
cDNA from thioguanine-resistant clones indicated that the mutation spectrum of BPDE is
similar in both wild type and Polr( cells. Tandem mutations were only seen in the wild
type cells (10.5%), whi le only one deletion mutation was seen in the Polr( cells (5 .6%).
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35-0-1
35d-l
68-32
83-2
68-13
68·7
68-U

35d-2
68-3
68-2
68-6
66-19
68-35
68-33
68-9
68-15
83·18
68-26
68-25

Mutation Typ@
A>C
A>C
A>G
A>T
G>A
G>A
G>A
G>T
G>T
G>T
G>T
G>T
G>T
G>T
G>T
G>T
G>T
CG»GT
GG»CC

Nucl@otid@ Strand
~~9
T
~~9
T
T
~91
lIT
1
1fT
2Z
617
1fT
617

1fT

197
197
230
419
563
569
601

IJT
liT
lIT
1fT
I-JT
lIT
lIT
lIT
liT
IJT

617

624

88
612-3

m

~18 ·9

IJT

Sampl@
~S3-2-t

C1
-tSa-28
483-26
A1
48a-l0
48-1A-6
48a-19
H1
C
48-1A-1
48a-14
81
48a-25
G1
48·1 8·3
H

48a·33

Mutation Typ@
A>G
A>G
G Deletion
G>A
G>A
G>A
G>C
G>T
G>T
G>T
G>T
G>T
G>T
G>T
G>T
G>T
G>T
G>T

Nucl@otid@ Strand
155
1fT
-t97
lIT
337
1fT
197
1fT
lIT
209
27
1fT
566
1fT
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liT
123
lIT
129
lIT
208
lIT
208
lIT
212
liT
1fT
3
398
IJT
420
1fT
569
1fT
88
1fT

Table 4-2. Hprt mutant sequences_ Isolation and sequencing of individual thioguanineresistant clones after BPDE treatment revealed that the mutation spectrum in wild type
(n= 19 unique mutations) and POly/-I- Pob +1+ cells (n= 18 unique mutations) both consisted
primarily of G>T transversions originating from BPDE lesions on the nontranscribed
strand_ The nucleotide column lists the base pair position of the mutation relative to the
HprtcDNA.
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DISCUSSION
Purified Pol t has been characterized in the error-prone bypass of BPDE lesions
[77], but the cellular role of this enzyme in bypassing bulky adducts induced by
environmental carcinogens remains unclear. As a first step towards extending our UV
studies to carcinogenesis by B[a]P, we first characterized the cellular role of Pol t after
treatment with the active metabolite BPDE. Using primary ear fibroblasts from Polr(
and Pol/- mice, we discovered that loss of either enzyme reduced the mutation frequency
induced by 150 nM BPDE by approximately 80%. The mutation frequency in the double
knockout cells was indistinguishable from either single knockout, indicating that Pol 11
and Pol t are epistatic in the bypass of BPDE lesions. In the absence of either Pol 11 or
Pol t, it is likely that Pol K performs bypass ofBPDE DNA damage. Purified Pol

K

bypasses BPDE lesions in an accurate manner [76,77,161], and experiments in PoIK-1mouse embryonic fibroblasts show elevated BPDE-induced mutation frequency in the
absence of this enzyme [81]. The faithful nature of Pol K BPDE lesion-bypass could
explain the low mutation frequency in Pob( and Pol(l- cells.
The mechanism of bypass involving both Pol 11 and Pol t is possibly a two-step
model ofTLS [161] where both enzymes are a part of the molecular complex required for
efficient bypass synthesis. Following this model, Pol 11 would perform direct lesion
bypass synthsis, frequently making errors [77]. Pol K or 1;; could perform the extension
step and leave a suitable DNA template for the continuation of normal replication. It is
unlikely that Pol t is involved in the direct bypass of BPDE due to the fact that the
purified protein is blocked by this adduct [77]. Pol t has also never been characterized as
an extender in a two-polymerase model, so it is likely that Pol t is not involved in the
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extension step ofBPDE bypass. Since POll is not likely to be directly involved in BPDE
bypass synthesis and yet its absence still results in reduced mutation frequency, we
hypothesize that this protein is a necessary component of the TLS complex. Without Pol
1,

the multi subunit complex necessary for the proposed two-step bypass of BPDE could

become unstable, allowing the direct bypass synthesis by the secondary Y -famly Pol K.
The relative fidelity of Pol K on the BPDE lesion template would explain the reduced
mutation frequency in our Pob'( and Pol/- cells.
It is important to note that Y-family polymerases are recruited to stalled

replication forks by protein-protein interactions. Y -family polymerases all have novel
ubiquitin binding regions which mediate their preferential binding to monoubiquitylated
PCNA [75], a post-translational modification that is made by the Rad6/Rad18 complex
after replication fork stalling. This interaction with monoubiquitylated PCNA appears to
be critical to the initiation ofTLS. It has also been shown that Rad18 directly shuttles
Pol TJ to the site of replication forks stalled at UV -induced DNA damage [44]. This
interaction is mediated by the preferential interaction of Pol TJ with phosphorylated Rad18
[162]. The demonstrated central role of protein-protein interactions in promoting
functional TLS indicates that the proposed model ofBPDE bypass requiring both Pol TJ
and POll for the stability of a multi protein complex is plausible.
Another explanation for the very low mutation frequency in cells lacking Pol TJ
and/or POll is that BPDE lesions are tolerated using template switching, an error-free
method of damage avoidance where the nascent DNA strand is used as an undamaged
homologous template. Replacing mutagenic TLS with error-free template switching
could also account for the reduced mutation frequency in Polr( andPo/z-1- cells. This
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method of damage avoidance is likely to increase at least slightly in our knockout cells if
our hypothesis of an unstable TLS complex is true, as even accurate TLS by Pol K would
require association with such a multiprotein complex to function.
Despite the fact that the number of TGf clones isolated was too small for
statistical analysis, we can draw some conclusions about the nature of the mutation
spectrum of the active V-family polymerase in each genotype examined. Wild type and

Polr( Poll +/+ cells showed mutation spectra that were very similar. This suggests that
Pol 11 either does not directly catalyze TLS across from BPDE lesions, or another
polymerase takes over TLS in its place with the same mutation spectrum. If Pol 11 is not
directly involved in the lesion bypass step, the most likely enzyme to perform this
function would be Revl. Evidence in yeast indicates that Rev1 is required with Pol 11 and
Pol K for mutagenic BPDE bypass [31]; it is therefore possible that both Pol 11 and Pol

t

are necessary for the formation of a TLS complex, and that loss of either enzyme results
in a disruption in this predominant mutagenic bypass pathway. There was a trend
towards increased tandem mutations in wild type cells (% of total) versus small deletions
in Polr( cells, which could indicate a change in the active bypass polymerase. This
slight change in mutation spectrum could suggest that Pol 11 is the active bypass
polymerase in wild type cells and displays relatively high processivity on the BPDE
lesion template, rarely adding two incorrect bases rather than one. In Polr( cells, Rev 1
could perform mutagenic lesion bypass, preferentially skipping a base a causing a
deletion and giving rise to the shifted mutation spectrum.
While we were able to isolate and sequence approximately equal numbers of TG f
clones from wild type and Polr( cells, we repeatedly encountered low replating
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efficiencies in the thioguanine selection of Pol(/- and Polr/ Pol(/- cells. We optimized
the TG dose and selection time in an attempt to make the clones more easily visible for
isolation, but the small number ofTGT clones we were able to isolate did not yield cDNA
of sufficient quality for peR amplification of the Hprt gene.
In conclusion, we have shown that Pol l) and Pol 1 participate in mutagenic
translesion synthesis past BPDE-induced DNA damage. These two enzymes likely
participate in the same mutagenic bypass pathway, such that loss of either Poll) or Poll
disrupts mutagenic TLS and allows for a more faithful damage tolerance mechanism,
likely TLS by Pol K or template switching. This is the first indication that Pol 1 is
involved in the cellular response to BPDE; it also represents the first step in applying our
findings from studies of Poll in a UV model to the effects ofBPDE.
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CHAPTER V

CONCLUSIONS AND FUTURE DIRECTIONS

The role of Y -family polymerases is expanding rapidly to include somatic
hypermutation [21], nucleotide excision repair synthesis [83], and cell cycle checkpoint
function [80]. Despite great advances in our understanding of the roles of these enzymes
in mammalian systems, the cellular role of Pol t remains unknown. The purified protein
has been characterized in the inaccurate bypass of numerous damaged DNA templates
[77,163,164,165]. It is also known that Pol t is responsible for the high UV -induced
mutation frequency in XP variant patients who lack Pol 11 [62].
Studies in this dissertation were designed to investigate the potential role of Pol t
outside TLS. Our hypothesis that Pol t could have a role in regulating other cellular
functions was based on a previous report [63] that Poh-/- have reduced UV-induced
mutations in their cells, but the mice develop cancer more quickly. We have evidence,
discussed in Chapter II, suggesting that the disparity between mutation frequency and
tumor latency is due to the regulation of the mitotic spindle checkpoint by Pol 1. This
finding is unexpected and novel, and bears further investigation; important questions
remain about the mechanism of checkpoint regulation by Pol 1. Our initial findings
should first be replicated in another cell type, preferably human. Then the function of the
spindle assembly checkpoint could be directly analyzed after genetic manipulation of the
cells; Poll or Rad18 knockdown could be used as specific and general TLS inhibitors,
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and cytochalasin B or aurora B kinase inhibitors could be used to block cells at
cytokinesis. Fluorescent tagged recombinant POll could be expressed in synchronized
cells for the examination of Pol 1 at the kinetochore. The purpose of these proposed
studies is to determine the exact nature of the regulation of the mitotic checkpoint by Pol
1.

Plosky et a/ reported that ~ 30% of Poli clones in a yeast two hybrid screen were found

to interact with clones encoding ubiquitin precursor proteins [166]. Therefore, it is
possible that ubiquitin signaling could playa role in the activity of POll in mitotic
checkpoint regulation. It is also interesting to note that Pol TJ-deficiency caused a slight
but significant increase in the percentage ofbinucleated cells. Future studies should
investigate whether Pol TJ also plays a role in the regulation of the mitotic checkpoint, and
whether this regulation involves the entire Y family ofpolymerases or is linked to TLS.
We found in Chapter III that loss of Pol 1 in an isogenic, cancer prone background
caused a trend towards reduced cancer latency in mice. It is possible that the Xpadeficiency of this model rendered the effect sizes too small for statistical differences
between groups to be realized with the sample sizes used. Therefore, we propose future
studies using isogenic Xpa +1+ mice to increase the latency of the control group and
therefore increase the effect sizes of the experimental groups. Future studies should also
include at least 30 mice per genotype in order to be sufficiently powered to detect
differences among groups. One major question raised in Chapter III is why we did not
see multinucleated cells inXpa-l - Poh-I - mice. Future studies should investigate tissues of
Po/(I- mice in multiple strains in order to determine if background differences playa role

in the observed discrepancy between our cell culture and in vivo data.
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In Chapter IV we analyzed the role of Polland Pol 11 in BPDE mutagenesis. We
propose that these studies serve as the foundation for future work into Poll-mediated
regulation ofBPDE-induced checkpoints. It is known that Pol K is required for escape
from an intra-S phase checkpoint induced by BPDE [80], but future studies on POll
should focus on activation of the mitotic checkpoint. It is feasible that POll is active in
the regulation of cytokinesis in more conditions that UV -induced DNA damage. It would
therefore be of interest to examine whether BPDE activates the mitotic checkpoint in
wild type cells, which has not been studied, and whether loss of POll alters this activity.
In conclusion, we have found a novel role for the Y-family DNA polymerase 1 in
activating the mitotic spindle assembly checkpoint after UV -induced DNA damage. In
the absence of POll, cells proceed through mitosis but do not undergo cytokinesis and
give rise to a tetraploid population. This is one possible explanation of the observed
tumor suppressor function of Polz in previous studies [63,64]. In Poll-deficient-mice, we
found a strong trend towards decreased latency ofUV-induced tumors. Finally, we found
that POll is involved in mutagenic TLS of BPDE-induced DNA damage. These studies
support POll as an important candidate for future investigation and a potentially and as
yet unrecognized regulator of mitotic progression.
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7-aminoactinomycin D

ANOVA analysis of variables
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base excision repair

BPDE

benzo[ a ]pyrene dihydrodiolepoxide

BrdU

bromodeoxyuridine

CPD

cyclobutane pyrimidine dimer

FACS

fluorescence activated cell sorting

FDR

false discovery rate

Hprt

hypoxanthine guanine phosphoribosyltransferase
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Ingenuity Pathway Analysis

IVT

in vitro transcription

MED

minimal erythemal dose

NER

nucleotide excision repair

PCNA

proliferating cell nuclear antigen

Pol~

DNA polymerase zeta

PolTJ

DNA polymerase eta
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DNA polymerase iota

POlK

DNA polymerase kappa

SNP

single nucleotide polymorphism

SUMO

small ubiquitin-like modifier
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